Potential use of convalescent plasma for SARS-CoV-2 prophylaxis and treatment in immunocompromised and vulnerable populations
Author:
Affiliation:
1. North-Western Tuscany Blood Bank, Pisa University Hospital, Pisa, Italy
2. Department of Hematology and Transfusion Medicine, Carlo Poma Hospital, Mantua, Italy
Publisher
Informa UK Limited
Subject
Drug Discovery,Pharmacology,Molecular Medicine,Immunology
Link
https://www.tandfonline.com/doi/pdf/10.1080/14760584.2021.1932475
Reference73 articles.
1. Focosi D, Farrugia A. Urgent need to regulate convalescent plasma differently from thawed plasma,
2. Convalescent Plasma Therapy for COVID-19: State of the Art
3. Gonzalez SE, Regairaz L, Salazar M, et al. Timing of Convalescent plasma administration and 28-day mortality for COVID-19 pneumonia. medrXiv 2021;2002(2002):21250758 (2021.
4. Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19
5. Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Combined antiviral therapy as effective and feasible option in allogenic hematopoietic stem cell transplantation during SARS-COV-2 infection: a case report;Frontiers in Oncology;2024-02-13
2. The Role of Convalescent Plasma in COVID-19: A Conclusive Post-Pandemic Review;Life;2023-12-11
3. Cytokine, Anti-SARS-CoV-2 Antibody, and Neutralizing Antibody Levels in Conventional Blood Donors Who Have Recovered from COVID-19;Transfusion Medicine and Hemotherapy;2023-09-22
4. What have we learned from a case of convalescent plasma treatment in a two-time kidney transplant recipient COVID-19 patient? A case report from the perspective of viral load evolution and immune response;Frontiers in Nephrology;2023-06-23
5. Rising anti-SARS-CoV-2 titer in a human immunoglobulin preparation;International Journal of Blood Transfusion and Immunohematology;2023-04-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3